0000921895-19-002468.txt : 20190927
0000921895-19-002468.hdr.sgml : 20190927
20190927172322
ACCESSION NUMBER: 0000921895-19-002468
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190918
FILED AS OF DATE: 20190927
DATE AS OF CHANGE: 20190927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MacDougall Ann L.
CENTRAL INDEX KEY: 0001685788
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 191123051
MAIL ADDRESS:
STREET 1: C/O OPIANT PHARMACEUTICALS, INC.
STREET 2: 401 WILSHIRE BOULEVARD, 12TH FLOOR
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER
STREET 2: 47TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: 646-975-2500
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER
STREET 2: 47TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
3
1
form312274mac_09272019.xml
OWNERSHIP DOCUMENT
X0206
3
2019-09-18
0
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001685788
MacDougall Ann L.
610 WEST END AVE
NEW YORK
NY
10024
0
0
1
1
See Explanation of Responses
Common Stock, $0.0013 par value
0
D
The Reporting Person may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ Ann MacDougall
2019-09-27